Filtered By:
Specialty: Neurology
Condition: Dementia

This page shows you your search results in order of relevance. This is page number 19.

Order by Relevance | Date

Total 1006 results found since Jan 2013.

Prognostic Factors for Cognitive Decline After Intracerebral Hemorrhage Clinical Sciences
Conclusions— Prognostic factors for cognitive decline after ICH are already present when ICH occurs, suggesting a process of ongoing cognitive impairment instead of new-onset decline induced by the ICH itself.
Source: Stroke - September 28, 2015 Category: Neurology Authors: Benedictus, M. R., Hochart, A., Rossi, C., Boulouis, G., Henon, H., van der Flier, W. M., Cordonnier, C. Tags: Acute Cerebral Hemorrhage Clinical Sciences Source Type: research

Increasing Skeletal Muscle Mass Could Prevent Stroke (P1.177)
Conclusion: High SMM group had low WMC/SI, especially in men. Increased SMM by muscle strengthening exercise may prevent stroke.Disclosure: Dr. Minn has nothing to disclose. Dr. Suk has nothing to disclose. Dr. Koh has nothing to disclose. Dr. Hwang has nothing to disclose. Dr. Park has nothing to disclose. Dr. Lee has nothing to disclose. Dr. Song has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Minn, Y. K., Suk, S. H., Koh, I. S., Hwang, S.-H., Park, J. H., Lee, J. H., Song, H. Tags: Cerebrovascular Disease: Risk Factors and Prevention Source Type: research

PRISM II: Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(R)) for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Combined Results of a Multicenter Open-Label Study (P2.225)
Conclusion: The open-label PRISM II study supports DM/Q effectiveness for PBA irrespective of underlying etiology. Study supported by: Avanir Pharmaceuticals, Inc.Disclosure: Dr. Siffert has nothing to disclose. Dr. Hammond has nothing to disclose. Dr. Alexander has nothing to disclose. Dr. Cutler has received personal compensation for activities with Abbott, AstraZeneca, Bristol-Myers Squibb, Forest, GlaxoSmithKline, Lilly, Merck, Novartis, Ortho-McNeil-Janssen, Otsuka, Pamlab, Pfizer, Shire, and Sunovion. Dr. D'Amico has received personal compensation for activities with Avanir Pharmaceuticals, Inc. Dr. Doody has receive...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Siffert, J., Hammond, F., Alexander, D., Cutler, A., D'Amico, S., Doody, R., Sauve, W., Zorowitz, R., Davis, C., Shin, P., Ledon, F., Yonan, C., Formella, A. Tags: Aging and Dementia: Therapeutics Source Type: research

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and post-stroke dementia: a hospital-based study from northern Iran
This study aimed to answer the following question: does BDNF Val66Met polymorphism prognosticate survival status and risk of post-stroke dementia (PSD)? In a retrospective cohort study, 206 patients with ischemic stroke (IS) entered the study. They were consecutively being admitted to the neurology clinic in Poursina Hospital (northern Iran) from 2012 to 2014. The diagnosis of PSD was based on DSM-5 criteria. The current and the premorbid cognitive statuses of the patients were respectively assessed through the third edition of Addenbrooke’s Cognitive Examination and the Informant Questionnaire on Cognitive Decline in th...
Source: Neurological Sciences - April 11, 2016 Category: Neurology Source Type: research

Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Conclusions Piracetam plays a limited role in the rehabilitation of overall language impairment and only benefits written language ability at the end of trials. Its effect on overall linguistic level and written language tends to emerge within a short period and declines thereafter.
Source: CNS Drugs - May 27, 2016 Category: Neurology Source Type: research

Dl-3-n-butylphthalide can improve the cognitive function of patients with acute ischemic stroke: a prospective intervention study.
DISCUSSION: Dl-3-n-butylphthalide could significantly improve the cognitive function of AIS patients 1 month after stroke. Hcy was involved in the incidence of VD 1 month after AIS. However, further studies are necessary because of differences between groups at baseline. PMID: 28145815 [PubMed - as supplied by publisher]
Source: Neurological Research - February 2, 2017 Category: Neurology Tags: Neurol Res Source Type: research

White matter hyperintensity reduction and outcomes after minor stroke
Conclusions: Some WMH may regress after minor stroke, with potentially better clinical and brain tissue outcomes. The role of risk factor control requires verification. Interstitial fluid alterations may account for some WMH reversibility, offering potential intervention targets.
Source: Neurology - September 4, 2017 Category: Neurology Authors: Wardlaw, J. M., Chappell, F. M., Valdes Hernandez, M. d. C., Makin, S. D. J., Staals, J., Shuler, K., Thrippleton, M. J., Armitage, P. A., Munoz-Maniega, S., Heye, A. K., Sakka, E., Dennis, M. S. Tags: MRI, Vascular dementia, Infarction ARTICLE Source Type: research

Thrombolysis in acute ischemic stroke in patients with dementia: A Swedish registry study
Conclusions: Younger patients with dementia and AIS are less likely to receive IVT. Among patients receiving thrombolysis, there are no differences in sICH or death, although patients with dementia have worse accommodation and functional outcomes at 3 months.
Source: Neurology - October 30, 2017 Category: Neurology Authors: Zupanic, E., von Euler, M., Kareholt, I., Contreras Escamez, B., Fastbom, J., Norrving, B., Religa, D., Kramberger, M. G., Winblad, B., Johnell, K., Eriksdotter, M., Garcia-Ptacek, S. Tags: Prognosis, All Cognitive Disorders/Dementia, Cohort studies, Infarction ARTICLE Source Type: research

Chronic cerebral hypoperfusion induces post-stroke dementia following acute ischemic stroke in rats
Post-stroke dementia (PSD) is one of the major consequences after stroke. Chronic cerebral hypoperfusion (CCH) can induce vascular cognitive impairment and potentiate amyloid pathology. We investigated how CCH...
Source: Journal of Neuroinflammation - November 9, 2017 Category: Neurology Authors: Dong Bin Back, Kyoung Ja Kwon, Dong-Hee Choi, Chan Young Shin, Jongmin Lee, Seol-Heui Han and Hahn Young Kim Tags: Research Source Type: research

Mechanisms of demyelination and remyelination in the young and aged brain following white matter stroke.
Abstract Subcortical white matter stroke (WMS) accounts for 25% of all incidences of stroke and results in severe motor and cognitive disability. WMS stands as the second leading cause of dementia and is immensely prevalent in older adults. In a startlingly statistic, a majority of human beings will present WMS by 80 years of age. Early ischemic lesions produced by WMS are asymptomatic and termed "silent strokes". WMS is, however, progressive with both the size of the lesions and their distribution, increasing as patients age. Pathological analyses in both postmortem human tissue samples and mouse models of WMS ...
Source: Neurobiology of Disease - July 19, 2018 Category: Neurology Authors: Marin MA, Carmichael ST Tags: Neurobiol Dis Source Type: research

Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or  TIA
AbstractPost-stroke dementia is common but has heterogenous mechanisms that are not fully understood, particularly in patients with atrial fibrillation (AF)-related ischaemic stroke or TIA. We investigated the relationship between MRI small-vessel disease markers (including a composite cerebral amyloid angiopathy, CAA, score) and cognitive trajectory over 12  months. We included patients from the CROMIS-2 AF study without pre-existing cognitive impairment and with Montreal Cognitive Assessment (MoCA) data. Cognitive impairment was defined as MoCA<  26. We defined “reverters” as patients with an “acute” MoCA (...
Source: Journal of Neurology - March 6, 2019 Category: Neurology Source Type: research

Vascular-brain Injury Progression after Stroke (VIPS) study: concept for understanding racial and geographic determinants of cognitive decline after stroke
Cognitive impairment and dementia (CID) are major public health problems with substantial personal, social, and financial burdens. African Americans are at a heightened risk for Vascular Cognitive Impairment (VCI) compared to European Americans. Recent lines of evidence also suggest a high burden of Post-stroke VCI among indigenous Africans. A better understanding of the cause(s) of the racial disparity in CID, specifically VCI, is needed in order to develop strategies to reduce it.We propose and discuss the conceptual framework for a unique tri-population, trans-continental study titled The Vascular brain Injury Progressi...
Source: Journal of the Neurological Sciences - February 18, 2020 Category: Neurology Authors: Fred Stephen Sarfo, Rufus Akinyemi, George Howard, Virginia J. Howard, Kolawole Wahab, Mary Cushman, Deborah A. Levine, Adesola Ogunniyi, Fred Unverzagt, Mayowa Owolabi, Bruce Ovbiagele Tags: Review Article Source Type: research

Post-stroke dementia and permanent institutionalization
Dementia is among the most frequent causes of institutionalization. To serve the purpose of preventive strategies, there are no follow-up studies that have evaluated the actual impact of post-stroke dementia on institutionalization. We therefore compared the institutionalization rate and length of stay in an institutional care facility of patients with post-stroke dementia with stroke patients without dementia.
Source: Journal of the Neurological Sciences - January 2, 2021 Category: Neurology Authors: Gerli Sibolt, Sami Curtze, Hanna Jokinen, Tarja Pohjasvaara, Markku Kaste, Pekka J. Karhunen, Timo Erkinjuntti, Susanna Melkas, Niku K.J. Oksala Source Type: research

Coffee or Tea? Drinking Both Tied to Lower Stroke, Dementia Risk Coffee or Tea? Drinking Both Tied to Lower Stroke, Dementia Risk
Drinking coffee or tea reduces the risk for stroke and dementia. But drinking both reduces stroke risk by 30% and dementia risk by 28%.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - November 16, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Normal left atrial diameter is associated with better performance on a cognitive screener among a cohort of ischemic stroke patients
ConclusionsIn this prospective study, among ischemic stroke patients with a LAD within the normal range, a 1 mm increase in LAD was associated with higher scores on a telephone cognitive battery, without an association found among those with a LAD >4 cm.
Source: Frontiers in Neurology - November 24, 2022 Category: Neurology Source Type: research